These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8724603)

  • 1. [Effect of sn-2-acetylated analogs of phosphatidalic acid on release and aggregation of human platelets].
    Muzia GI; Kulikov VI
    Biokhimiia; 1996 Mar; 61(3):455-60. PubMed ID: 8724603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation.
    Kulikov VI; Muzya GI
    Biochemistry (Mosc); 2000 Apr; 65(4):427-30. PubMed ID: 10810178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of the activation of rabbit platelets induced by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activation factor)].
    Kozlov VK; Filatova LV; Kulikov VI; Markosian RA; Bergel'son LD
    Biull Eksp Biol Med; 1985 Oct; 100(10):410-2. PubMed ID: 4052603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human platelet aggregation by amides and ester of salicylic acid with platelet-activating factor analogs.
    Kulikov VI; Muzya GI
    Biochemistry (Mosc); 2001 Jun; 66(6):658-61. PubMed ID: 11421815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histamine release from human leukocytes after treatment with 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) and its structural analogs].
    Orlov SM; Kulikov VI; Pol'ner AA; Bergel'son LD
    Biokhimiia; 1985 Apr; 50(4):680-5. PubMed ID: 2408682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of interaction of a plasmalogenic analog of platelet-activating factor with human platelets.
    Kulikov VI; Muzya GI
    Biochemistry (Mosc); 1999 Jun; 64(6):631-5. PubMed ID: 10395976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acyl and plasmalogen analogs of platelet activating factor--new lipid cellular bioregulators].
    Kulikov VI; Muzia GI
    Biokhimiia; 1992 Jun; 57(6):803-16. PubMed ID: 1420585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of cytoplasmic calcium in human platelets by the phospholipid platelet-activating factor 1-O-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine.
    Valone FH; Johnson B
    J Immunol; 1985 Feb; 134(2):1120-4. PubMed ID: 2578151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-O-hexadec-1'-enyl-2-acetyl-sn-glycero-3-phosphocholine and its biological activity.
    Nakayama R; Yasuda K; Satouchi K; Saito K
    Biochem Biophys Res Commun; 1988 Mar; 151(3):1256-61. PubMed ID: 3355555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective activation of human monocytes by the platelet-activating factor analog 1-O-hexadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine.
    Rose JK; Debs RA; Philip R; Ruis NM; Valone FH
    J Immunol; 1990 May; 144(9):3513-7. PubMed ID: 2329280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 1-O-alkyl-, 1-O-alk-1'-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family.
    O'Flaherty JT; Tessner T; Greene D; Redman JR; Wykle RL
    Biochim Biophys Acta; 1994 Jan; 1210(2):209-16. PubMed ID: 8280772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of aldehydogenic and acyl structural analogs of platelet activating factor on the formation of superoxide radicals by human blood leukocytes].
    Kuznetsova TI; Kulikov VI
    Biokhimiia; 1992 Jan; 57(1):16-20. PubMed ID: 1327185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues.
    Ostermann G; Kertscher HP; Till U
    Biomed Biochim Acta; 1985; 44(2):K17-23. PubMed ID: 4004829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural features of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) required for hypotensive and platelet serotonin responses.
    Blank ML; Cress EA; Lee TC; Malone B; Surles JR; Piantadosi C; Hajdu J; Snyder F
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):3-20. PubMed ID: 7146619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation].
    Lakin KM; Kulikov VI; Manevich EM; Muliar AG; Shvets VI
    Farmakol Toksikol; 1988; 51(4):113-23. PubMed ID: 2847936
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interaction of 1-O-alkyl-2-methoxy-sn-glycero-3-phosphocholine and platelet activating factor with blood and tumor cells].
    Muzia GI; Orlov SM; Berdyshev EV; Kulikov VI
    Biokhimiia; 1994 Jul; 59(7):1054-61. PubMed ID: 7948414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis and platelet aggregating activity of structural analogs of platelet-activating factor with a heterocyclic head group].
    Kertscher HP; Ostermann G
    Pharmazie; 1987 Nov; 42(11):713-5. PubMed ID: 3438334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkyl-ether phosphoglycerides influence calcium fluxes into human endothelial cells.
    Bussolino F; Aglietta M; Sanavio F; Stacchini A; Lauri D; Camussi G
    J Immunol; 1985 Oct; 135(4):2748-53. PubMed ID: 2411812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Formation of a structural isomer of platelet activating factor during acetylation of 1-alkyl-sn-glycero-3-phosphocholine].
    Chupin VV; Ostapenko OV; Klykov VN; Anikin MV; Serebrennikova GA
    Bioorg Khim; 1993 Nov; 19(11):1111-21. PubMed ID: 8285924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
    Keraly CL; Benveniste J
    Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.